{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:06:22Z","timestamp":1792080382674,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.euf.2017.12.004","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T19:32:06Z","timestamp":1515612726000},"page":"514-516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Male Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male"],"prefix":"10.1016","volume":"3","author":[{"given":"Kamran","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Hatzimouratidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Muneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2017.12.004_bib0005","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1210\/jc.2007-1972","article-title":"Hypothalamic\u2013pituitary\u2013testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study","volume":"93","author":"Wu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euf.2017.12.004_bib0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.exger.2004.03.023","article-title":"The health of normally aging men: the Massachusetts Male Aging Study (1987\u20132004)","volume":"39","author":"O\u2019Donnell","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.euf.2017.12.004_bib0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13685538.2014.908460","article-title":"Performance of Massachusetts Male Aging Study (MMAS) and Androgen Deficiency in the Aging Male (ADAM) questionnaires in the prediction of free testosterone in patients aged 40 years or older treated in outpatient regimen","volume":"17","author":"Cabral","year":"2014","journal-title":"Aging Male"},{"key":"10.1016\/j.euf.2017.12.004_bib0020","unstructured":"Dohle GR, Arver S, Bettocchi C, Jones TH, Kliesch S. EAU guidelines on male hypogonadism. http:\/\/uroweb.org\/guideline\/male-hypogonadism."},{"key":"10.1016\/j.euf.2017.12.004_bib0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/1008-682X.122336","article-title":"Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment","volume":"16","author":"Huhtaniemi","year":"2014","journal-title":"Asian J Androl"},{"key":"10.1016\/j.euf.2017.12.004_bib0030","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jamainternmed.2013.6895","article-title":"Trends in androgen prescribing in the United States, 2001\u20132011","volume":"173","author":"Baillargeon","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.euf.2017.12.004_bib0035","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.fertnstert.2008.08.094","article-title":"Androgen deficiency in the aging male","volume":"90","author":"Practice Committee of American Society for Reproductive Medicine, Society for Male Reproduction and Urology","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.euf.2017.12.004_bib0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/EJE-08-0601","article-title":"Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations","volume":"159","author":"Wang","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.euf.2017.12.004_bib0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2007.51","article-title":"Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial","volume":"299","author":"Emmelot-Vonk","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2017.12.004_bib0050","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2017.12.004_bib0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/ijcp.12235","article-title":"The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study)","volume":"68","author":"Hackett","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.euf.2017.12.004_bib0060","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bju.13578","article-title":"Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men","volume":"119","author":"Debruyne","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2017.12.004_bib0065","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.296.19.2351","article-title":"Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial","volume":"296","author":"Marks","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2017.12.004_bib0070","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/heartjnl-2015-309223","article-title":"Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality","volume":"102","author":"Anderson","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.euf.2017.12.004_bib0075","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamainternmed.2015.1573","article-title":"Comparative safety of testosterone dosage forms","volume":"175","author":"Layton","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.euf.2017.12.004_bib0080","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euf.2017.12.004_bib0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.maturitas.2015.11.003","article-title":"EMAS position statement: testosterone replacement therapy in the aging male\u200f","volume":"84","author":"Dimopoulou","year":"2016","journal-title":"Maturitas"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456917302730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456917302730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:45:58Z","timestamp":1762497958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456917302730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":17,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2405456917302730"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2017.12.004","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Male Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2017.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}